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Abstract
Fragile X syndrome (FXS) is characterized by hallmark features of gaze avoidance, reduced
social approach, and social anxiety. The development of therapeutics to manage these symptoms has been
hindered, in part, by the lack of sensitive outcome measures. This study investigated the utility of a novel
eye tracking paradigm for indexing social avoidance-related phenotypes. Adolescent/young adult-aged
males with FXS (n=24) and typical development (n=23) participated in the study. Participants viewed
faces displaying direct or averted gaze and the first fixation duration on the eyes was recorded as an index
of initial stimulus registration. Fixation durations did not differ across the direction of gaze conditions in
either group, although the control group showed longer initial fixations on the eyes relative to the FXS
group. Shorter initial fixation on averted gaze in males with FXS was a robust predictor of the severity of
their social avoidance behavior exhibited during a social greeting context, whereas parent-reported social
avoidance symptoms was not related to performance in the semi-naturalistic context. This eye tracking
paradigm may represent a promising outcome measure for FXS clinical trials because it provides a
quantitative index that closely maps onto core social avoidance phenotypes of FXS, can be completed in
less than 20 minutes, and is suitable for use with individuals with low IQ.

Keywords: drug trials, social anxiety, gaze processing, gaze avoidance, eye contact
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A Novel Eye Tracking Paradigm for Indexing Social Avoidance-Related Behavior in Fragile X Syndrome
Fragile X syndrome (FXS) occurs when an expansion of >200 trinucleotide (CGG) repeats occurs
on the 5’ untranslated region of the Fragile X Mental Retardation-1 (FMR1) gene, located on the X
chromosome (Maddalena et al., 2001). This mutation results in hypermethylation, transcriptional
silencing, and failure to express the Fragile X Mental Retardation Protein (FMRP) that is needed for brain
development and function (Crawford, Acuna, & Sherman, 2001). FXS affects 1 in 7,000-10,000
individuals and represents the most common inherited cause of intellectual disability (ID; Hunter et al.,
2014). Mild to moderate ID is seen in the majority of males with the syndrome, who are typically more
severely affected than females who benefit from the protective effects of the second X chromosome
(Hagerman & Hagerman, 2002). In addition to cognitive impairment, the FXS phenotype is characterized
by high rates of co-occurring autism spectrum disorder (ASD), physiological hyperarousal, attention
deficits, and communication impairment (Finestack, Richmond, & Abbeduto, 2009; Garcia-Nonell et al.,
2008; Kaufmann et al., 2017; Klusek, Martin, & Losh, 2014b; Klusek, Roberts, & Losh, 2015; Munir,
Cornish, & Wilding, 2000). Social withdrawal, shyness, and social avoidance are also core features of the
phenotype, with as many as 60% of males with FXS meeting diagnostic criteria for social phobia
(Budimirovic et al., 2006; Cordeiro, Ballinger, Hagerman, & Hessl, 2011; Kaufmann, Capone, Clarke, &
Budimirovic, 2008).
Difficulty establishing and maintaining eye contact is one of the most ubiquitous behavioral
features of FXS (Hall, DeBernardis, & Reiss, 2006; Hessl, Glaser, Dyer-Friedman, & Reiss, 2006; Reiss
& Freund, 1992; Wolff, Gardner, Paccia, & Lappen, 1989). This characteristic is demonstrated by the
classic example of the “fragile X handshake” in which individuals with FXS willingly accept a handshake
during social greeting while physically turning away and avoiding eye contact (Wolff et al., 1989). Boys
with FXS make eye contact less frequently than their typically developing peers and children with other
neurodevelopmental disorders, such as Down syndrome (Hall et al., 2015; Hessl et al., 2006; Klusek,
Martin, & Losh, 2014a; Murphy, Abbeduto, Schroeder, & Serlin, 2007). The degree of reduced eye
contact is striking, with some studies documenting gaze aversion occurring 80-90% of the time during
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interaction with an examiner (Abbeduto et al., 2018; Hall et al., 2006; Hall et al., 2015; Hall, Lightbody,
Huffman, Lazzeroni, & Reiss, 2009). Poor eye contact is also persistent over the course of an interaction;
although eye contact may improve somewhat with time and familiarity, it typically does not normalize to
the level that would be expected in typically developing individuals (Roberts, Weisenfeld, Hatton, Heath,
& Kaufmann, 2007).
Poor eye contact in FXS is hypothesized to stem from heightened social anxiety, such that
individuals with FXS actively avoid eye contact because they perceive it to be threatening (e.g., Cohen,
Vietze, Sudhalter, Jenkins, & Brown, 1989). This hypothesis is based on an early behavioral observation
that children with FXS seemed to actively avoid mutual eye contact with their parents by waiting until
their parents looked away before returning their gaze (Cohen et al., 1989). Such active avoidance
behavior is consistent with hypervigilant-avoidant patterns of attentional bias that have been observed in
social anxiety in the general population, characterized by initial attention to threatening stimuli, followed
by avoidance (Bögels & Mansell, 2004; Garner, Mogg, & Bradley, 2006). In FXS, physiological
hyperarousal is thought to play a role in this process, contributing to anxiety and subsequent avoidance of
social demands (see Cohen, 1995; Klusek et al., 2015). Consistent with this hypothesis, neuroimaging
studies of gaze processing in males and females with FXS have documented atypical brain responses in
regions involved in anxiety and arousal, such as the amygdala and insula (Dalton, Holsen, Abbeduto, &
Davidson, 2008; Watson, Hoeft, Garrett, Hall, & Reiss, 2008).
Lower cortisol stress responses have also been detected in boys with FXS who make less frequent
eye contact, supporting the notion that avoiding mutual gaze may reduce physiological stress (Hessl et al.,
2006). Elevated skin conductance responses and heightened pupillary reactivity to emotional faces have
also been documented in individuals with FXS (Farzin, Rivera, & Hessl, 2009; Williams, Langdon, &
Porter, 2013). However, evidence of this relationship is mixed, as the extent of gaze avoidant behavior in
FXS does not correlate with arousal level indexed by heart rate measures (Hall et al., 2009) and there is
growing evidence to suggest that cardiac hyperarousal in FXS represents a generalized physiological state
that is not specific to social contexts (Klusek, Martin, & Losh, 2013; see Klusek et al., 2015 for review).
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Some recent evidence also suggests that gaze avoidance behavior is exhibited by individuals with
FXS regardless of social tasks demands. Murphy et al. (2007) compared gaze avoidance of matched
samples of boys with FXS, Down syndrome, and typical development during a naming task that was
experimentally manipulated for social vs. nonsocial context. Gaze avoidance was uniformly elevated in
the FXS group across both social and nonsocial conditions and, therefore, poor eye contact could not be
attributed to social task demands. The contributors to poor eye contact in FXS are likely multifactorial, as
other factors such as ASD symptoms (Roberts et al., 2007), language deficits (Hall et al., 2015), and
social cognition (Holsen, Dalton, Johnstone, & Davidson, 2008) have also been implicated in the eye gaze
behavior of individuals with FXS. Overall, there is a need for well-controlled investigations into the
relationship between social avoidance and atypical gaze behavior in FXS, which has implications for
theory and clinical practice.
In the present study, we used an experimental eye tracking paradigm to measure visual responses
to direct and averted gaze exposure, as well as associations with social avoidance symptoms, in a sample
of adolescent and young adult males with FXS. The study of differences in eye movement behavior in
response to exposure to direct vs. averted gaze can provide insight into how individuals monitor and
perceive interpersonal approach. Direct gaze signals intent to approach and, from an evolutionary
perspective, heightened sensitivity to this signal may confer a survival advantage via enhanced detection
of approaching predators (Emery, 2000). By contrast, averted gaze communicates motivational intent to
avoid interaction and enhances the perception of withdrawal-related emotions, such as fear and sadness
(Adams & Kleck, 2003). Because direct gaze provides a clear signal of another person’s intent to
approach and initiate social interaction, socially anxious individuals may perceive direct gaze as a threatrelated stimulus and respond with hypervigilance-avoidance behaviors. Exposure to direct gaze has also
been shown to elicit heightened physiological arousal in socially anxious individuals relative to averted
gaze (Wieser, Pauli, Alpers, & Mühlberger, 2009). Therefore, by contrasting responses to direct and
averted gaze exposure, we aimed to shed light on how individuals with FXS process fundamental
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approach-avoidance signals, which will inform mechanisms underlying socially avoidant behavior in this
group.
We also examined whether the looking behavior of males with FXS during the eye tracking
paradigm was predictive of socially avoidant behavior in a semi-naturalistic context (i.e., during initial
greeting with an unfamiliar adult). Because the lack of useful outcome measures has represented a
significant barrier to the success of FXS clinical trials (Budimirovic et al. 2017), there is value in
identifying accessible, objective measures that map onto core social phenotypes of FXS (Jacquemont et
al., 2014). Eye tracking indices are especially promising in this regard as they are generally quick,
objective, reliable, have automated data processing, and tap into fine-grained behaviors that may be
overlooked by rating scales and other observational methods (e.g., Farzin, Scaggs, Hervey, Berry-Kravis,
& Hessl, 2011). We posed the following research questions:
1. Does initial fixation on the eyes differ across FXS and age-matched controls, and do patterns differ
following exposure to direct and averted gaze? In the males with FXS who were expected to show
aversion to direct gaze (e.g., Cohen et al., 1989), we expected shorter initial fixation on direct gaze
relative to averted gaze, marking avoidance of the direct gaze. We expected the age-matched control
males to show longer initial fixation on the eyes relative to the males with FXS, with the former
showing a preference for direct over averted gaze, consistent with a large body of evidence
supporting attention to direct gaze as an innate, adaptive human trait (Baron-Cohen & Ring, 1994;
Emery, 2000; Farroni, Csibra, Simion, & Johnson, 2002).
2.

Can initial fixation in the eye region during the social gaze eye tracking paradigm predict the severity
of socially avoidant behavior exhibited by males with FXS? We hypothesized that longer first fixation
duration in response to eyes displaying direct, but not averted, gaze would predict more severe
examiner-rated and parent-reported social avoidance behavior in the males with FXS.
Methods
Participants
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The final participant sample included 24 males with FXS, aged 16-26 years (M = 19) and 23
typically developing males of a similar age (M=21 years, range = 19-26). Participant characteristics are
described in Table 1. The typically developing control males were recruited from the local university
community via word of mouth and flyers. Control males had no known history of developmental delays
or disorders, per self-report, and scored below ASD cut-offs on the Social Responsiveness Scale-2
(Constantino & Gruber, 2012). All participants with FXS had ID, with the mean nonverbal IQ at 39 (IQ
range = 36-56). Three additional males with FXS were recruited for the study but did not contribute data
due to failure to complete >80% of the eye tracking trials (two males were unable to follow the
instructions for calibration; one male refused to wear the head tracking sticker due to a sensory aversion).
FXS data were collected as part of a longitudinal study focused on language development in males with
FXS through adolescence and young adulthood (Abbeduto et al., 2019; Matherly et al., 2018), although
previous publications from this study have not reported eye tracking data. Participants with FXS were
recruited throughout the eastern and midwestern regions of the United States through social media,
outreach to the National Fragile X Foundation Community Support Networks, and the Research
Participant Registry Core of the Carolina Institute for Developmental Disabilities. All participants were
native English speakers and able to use two to three-word phrases (according to parent report), which
were part of the inclusionary criteria of the larger study. FXS (>200 CGG copies in the 5′-untranslated
region of FMR1) was confirmed via DNA analysis of peripheral blood.
Procedures
Data for the present study were collected in a research laboratory. Data for the FXS participants
were collected at either Time 2 or Time 3 of participation in the larger four-year longitudinal study. Either
Time 2 or Time 3 was chosen depending on staff availability and time constraints, given that this study
was a “convenience” study conducted outside the scope of the original parent study. The eye tracking task
was conducted in the morning of the second day of the two-day research protocol. The activities
preceding the eye tracking tasks on the second day of testing consisted of about an hour of standardized
language testing. Control participants were recruited for a one-time assessment that lasted about an hour
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and included the completion of a demographic form and the Social Responsiveness Scale-2 followed by
administration of the eye tracking task. All procedures were approved by the Institutional Review Board
(IRB) of the University of South Carolina and conform to the standards of the Declaration of Helsinki.
Parental consent and participant assent were obtained according to IRB regulations.
<INSERT TABLE 1 HERE>
Measures
Social Gaze Eye Tracking Paradigm. The social gaze paradigm was programmed using the
Experiment Builder software package (version 1.10, SR-Research Ltd, Ontario, Canada). This paradigm
was adapted from Wieser et al. (2009) and the modified version has been previously described in detail in
Klusek, Schmidt, Fairchild, Porter & Roberts (2017). Briefly, the eye gaze paradigm consists of a series
of 3D computer graphics of neutral female faces that display gaze that is either directed at the participant
or averted to the right or left. The trial began when participants were centrally fixated, which
corresponded to the center of the eye region on the graphic of the female face which was initially
presented with the eyes closed for 1200 ms. After that, the participant needed to look directly at the eye
region for 300 ms before the trial would proceed and the eyes of the face would open. After the eyes
open, the face displays either an averted or direct gaze for 6000 ms. In the unlikely event of track loss or
excessive drift preventing the detection of gaze on the closed eyes, the experimenter could exit the trial
and recalibrate as needed. In this case, the experiment continued with the next trial and the aborted trial
was presented at the end of the block of trials.
At the beginning of the experiment, the participant is instructed: "You are going to see a series of
faces on the screen. The faces will have their eyes closed. I want you to look within the eye region of the
face until the eyes open. After the eyes open, you can look anywhere you want on the screen". Stimuli
included 16 different females faces, with condition (i.e., direct, averted) shown at random until 16 trials
for each condition had been completed (32 trials total). Only female faces were included because females
faces were expected to elicit more robust responses than male faces (Wieser et al., 2009), and sex-of-
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stimulus effects were not of particular interest in the present study. Example stimuli are shown in Figure
1.
<INSERT FIGURE 1 HERE>
The Eyelink 1000 Plus (SR Research Ltd, Ontario, Canada) was used to record eye movements,
which were monocularly sampled at 500 Hz in remote mode to allow for head movement. Stimuli were
presented on a BEN-Q 2420T monitor (530mm x 300 mm, 1366 x 768 pixels, 60 Hz). Five-point
calibration and validation were performed preceding the experiment. Calibrations were accepted if the
average error was <.5° and the maximum error <1.00°. A single point drift check was presented before
each trial and drifts in the data were recorded. To prevent drift during the study, recalibration was
employed as needed. Data were collected in a well-lit room, with the participant seated approximately
750mm from the monitor. The Eyelink software default parameters were used to parse the online sample
data into fixations, saccades, and blinks. The parser algorithm is designed to detect saccades by utilizing
the instantaneous velocity and acceleration of the eye. A saccade signal is generated when the
instantaneous acceleration exceeds 8000° per second or the instantaneous velocity exceeds 30° per
second. Fixations are defined as periods without saccades but when the eye is present, whereas blinks
are times when the pupil is undetected. Data were analyzed using Dataviewer (version 2.41 SR
Research, Ontario, Canada).
An eye region area of interest was defined by a rectangle drawn around the eyes that subtended 8°
horizontally and 3° vertically (see Figure 1). The average first fixation duration within the eye area of
interest for each condition was extracted as the outcome variable. The first fixation duration reflects initial
stimulus registration and is often used as an index of stimulus saliency (Henderson, 2003). This index
does not require sustained attention to the stimulus, which is important given the low functioning level of
the participants with FXS. The design of the eye gaze paradigm, which checked participant’s eye position
online to ensure that participants were fixating within the eye region of the face when direct or averted
gaze was initiated, ensured that the first fixation duration captured the initial viewing response following
the opening of the eyes. Looking behavior that occurred after the first fixation on the eyes were not
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analyzed due to concerns regarding the validity of these data; many participants with FXS failed to attend
to the facial stimuli for the full display time, resulting in significant missing data after the initial fixation
on the eyes. All participants contributed valid data for the first fixation on the eyes for >80% of the trials.
A programming error caused 1 missing trial for one participant with FXS, 6 missing trials for another
participant with FXS, and 2 missing trials for one control participant; all other participants had complete
data.
Parent-reported social avoidance behavior. Social avoidance symptoms were measured in the
FXS group using the social avoidance subscale of the Anxiety Depression and Mood Scale (ADAMS;
Esbensen, Rojahn, Aman, & Ruedrich, 2003). The ADAMS is a 28-item caregiver report measure of
mood and anxiety symptoms normed for populations with ID. The social avoidance subscale captures
symptoms that align with the Diagnostic and Statistical Manual of Mental Health Disorder-5th Edition
(DSM-5; American Psychiatric Association, 2013) classification of social anxiety disorder. This subscale
includes questions such as “avoids others”, “spends much of time alone” and “avoids eye contact”. Items
are scored on a scale of 0-3, with 0 signifying “not a problem” and 3 signifying “severe problem”.
Possible raw scores for the subscale range from 0-21, with higher scores representing social avoidance
behavior of increased severity. Cronbach’s alpha for the social avoidance subscale of the ADAMS for the
present study was α = 0.66.
Examiner-rated social avoidance behavior. Social avoidance behavior of the individuals with
FXS was sampled from a semi-naturalistic context using the Social Avoidance Scale (formerly the Social
Approach Scale; Roberts et al., 2009; Roberts et al., 2018; Roberts et al., 2007). The scale is rated by
trained examiners based on the behaviors exhibited by the participants during the first minute of
interaction with the examiner after arrival at the research laboratory on the first day of the two-day
assessment. Behavior within the dimensions of physical approach, social shyness, and eye contact are
coded on a scale of 0-4 based on operational definitions, with a higher score indicating greater avoidance.
Physical approach is characterized by physical body movement towards and away from the examiner.
Social shyness is characterized by the amount the participant speaks, their reflection of interest in the
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examiner, and subtle changes in the region of the face reflecting wariness. Eye contact is characterized by
the estimated percentage of appropriate eye contact during the interaction.
The Social Avoidance Scale yields scores for each of the behavioral subdomains, as well as an
overall rating (i.e., the average across the three subscales). The scale was coded via the consensus of two
trained examiners who completed the scale immediately following the interaction with the participant.
Cronbach’s alpha for the Social Avoidance Scale across the three dimensions (i.e. physical movement,
facial expression, and eye contact) for the present study was α = 0.66. Inter-rater reliability prior to
consensus was recorded for 20% of samples and Weighted Cohen’s Kappas were 0.86 for the Total Score,
0.90 for the physical approach subscale, 0.89 for the social shyness subscale, and 0.67 for the eye contact
subscale. Kappa estimates ranging from 0.61-0.80 indicate “substantial” reliability and estimates ranging
from 0.81-1.0 indicate “almost perfect” reliability (Cohen, 1960).
ASD symptom severity. The Autism Diagnostic Observation Schedule-Second Edition (ADOS-2;
Lord et al., 2012) was administered by research-reliable doctoral-level clinicians as an index of ASD
symptom severity in the males with FXS. The ADOS-2 is a standardized, semi-structured assessment that
allows opportunities for communication, social interaction, play, and restricted and repetitive behaviors.
The comparison score was obtained as an index of overall symptom severity; scores range from 1-10,
with scores above a 3 consistent with a diagnosis of ASD. Given that ASD symptoms in adolescents and
adults with FXS show stability over time (Hernandez et al., 2009; Sabaratnam, Murthy, Wijeratne,
Buckingham, & Payne, 2003), the ADOS-2 data were collected only at the first annual assessment for
each participant in the larger longitudinal study. Thus, our measure of ASD symptom severity was
collected 1-2 years prior to the eye tracking measure. Inter-rater reliability conducted on 15% of the
administrations yielded 81% agreement for the algorithm items.
Nonverbal cognitive ability. Nonverbal cognitive ability was assessed in participants with FXS
using the Leiter International Performance Scale-Revised (Leiter-R) Brief IQ (Roid & Miller, 1997). The
Brief IQ consists of 4 subtests of the broader Visualization and Reception battery and provides a reliable
measure of nonverbal intelligence. The internal-consistency reliability coefficients for the Visualization
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and Reception battery subsets range from .75-.90 for the norming sample (Roid & Miller, 1997). Growth
scale value scores were used to avoid floor effects associated with standard scores in this sample with ID.
Results
Descriptive Statistics
Analyses were conducted in SAS 9.4. First, descriptive statistics were computed and data were
visually examined for normal distributions. The Box Cox transformation technique (Box & Cox, 1964)
was applied to correct for positive skew in the first fixation duration variable (λ = -1.00). No other
variables required transformation. Means, standard deviations, and ranges for each of the predictor and
outcome variables are presented in Table 2.
<INSERT TABLE 2 HERE>
Comparison of Initial Fixation on the Eyes across Males with FXS and Typically Developing Males
The first analysis tested differences between the males with FXS and their age-matched typically
developing peers on the duration of the first fixation within the eye region across conditions (averted
gaze, direct gaze). A linear mixed effects model was fit using maximum likelihood estimation with an
unstructured covariance matrix, specified using PROC MIXED in SAS 9.4 (SAS Institute, 2013).
Condition was specified as a fixed effect, nested within the individual. Group membership and its
interaction with condition were also included as fixed effects to test for their potential influences on
looking behavior. Results indicated a significant group effect, with the males with FXS having shorter
first fixation durations on the eyes relative to control participants (F [1, 44] = 28.36, p < .001). The main
effect of condition was not significant (F [1, 44] = 0.06, p = .815) and neither was the group-by-condition
interaction term (F [1, 44] = 0.02, p = .883), indicating that both groups responded to direct and averted
gaze in a similar manner.
Performance on the Social Gaze Eye Tracking Task as a Predictor of Social Avoidance
Parent-reported Social Avoidance Symptoms. General linear models were run to test the first
fixation duration in each condition as a predictor of the ADAMS social avoidance subscale. Nonverbal
cognitive level and ASD severity were covaried in these models. The model testing the first fixation
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duration in the direct gaze condition as a predictor of the ADAMS social avoidance subscale was not
significant (F [3, 20] = 2.26, p = .113, R2 = .25). The overall model testing the first fixation duration in the
averted condition was significant (F [3, 20] = 3.48, p = .035, R2 = .34). However, while the combined
influence of the first fixation duration, ASD symptom severity, and nonverbal cognition accounted for
significant variance in the ADAMS social avoidance score, no individual predictor accounted for
significant variance on its own. A trend was observed for the first fixation duration on the averted eyes to
account for unique variance in the ADAMS score (F [1, 20] = 3.02, p = .097), with a partial eta-squared
effect size (η2p) of 0.13 consistent with a “large” effect (Cohen, 1988). Nonverbal cognitive ability did not
account for significant variance in the ADAMS social avoidance score (F [1, 20] = 0.68, p = .419, η2p =
0.03), but a trend-level effect of a large effect size was observed for the influence of ASD severity in the
model (F [1, 20] = 4.19, p = .054, η2p = 0.17).
Examiner-rated Social Avoidance Behavior. Next, we tested whether looking behavior during
the eye tracking paradigm could predict social avoidance behavior exhibited during initial greeting with
an examiner. A general linear model tested the first fixation duration in each condition as predictors of the
Total Score on the Social Avoidance Scale, controlling for nonverbal cognitive level and ASD severity.
The Benjamini-Hochberg procedure (Benjamini & Hochberg, 1995) was applied to control for multiple
comparisons. The overall model testing the first fixation duration in the direct gaze condition was not
significant (F [3, 20] = 2,35, p = .103, R2 = .26). The model testing the first fixation duration in the
averted gaze condition accounted for significant variance in the Total Score of the Social Avoidance
Scale (F [3, 20] = 5.23, p = .008, R2 = .44). A significant effect for the first fixation duration in response
to averted gaze was detected (F [1, 20] = 8.64, p = .008), with a shorter first fixation duration associated
with increased socially avoidant behavior (see Figure 3). A partial eta-squared effect size (η2p) of 0.30 was
detected for this effect, consistent with a “large” effect (Cohen, 1988). Neither nonverbal cognitive ability
(F [1, 20] = 1.87, p = .187, η2p = 0.09) nor ASD severity (F [1, 20] = 0.95, p = .342, η2p = 0.05) accounted
for significant variance in the outcome.
<INSERT FIGURE 3 HERE>
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Association between Parent-report and Examiner-Rated Indices of Social Avoidance
Finally, to shed light on the added value of eye tracking measures relative to parent-report
measures of social avoidance that are commonly used in clinical trials, we conducted a follow-up analysis
testing the ADAMS social avoidance subscale as a predictor of the Social Avoidance Scale. The
combined effects of the ADAMS social avoidance subscale, nonverbal cognitive ability, and ASD
severity did not account for significant variance in the Social Avoidance Scale-Total Score (F [3, 20] =
2.21, p = .118, R2 = .25). The ADAMS social avoidance subscale was not a significant predictor of the
Social Avoidance Scale-Total Score (F [1, 22] = 1.38, p = .254), although the effect size was consistent
with a medium effect (η2p = .06). Nonverbal cognitive ability (F [1, 22] = 2.07, p = .166, η2p = .09) and
ASD severity (F [1, 22] = 0.81, p = .380, η2p = .04) did not contribute significantly to the model.
Discussion
FXS is characterized by gaze avoidance, reduced social approach, and social anxiety. The lack of
sensitive measurement tools for these core phenotypic features has proven a major barrier to evaluating
therapeutics in FXS clinical trials. This study investigated the utility of a novel experimental eye tracking
paradigm for indexing social avoidance-related behavior in males with FXS. A key finding was that the
social gaze eye tracking paradigm was successful at tapping subtle looking behaviors that mapped onto
meaningful phenotypic variation in social avoidance behavior. Indeed, performance on the eye tracking
paradigm was better able to predict avoidant behavior exhibited by the males in a semi-naturalistic
context than were social avoidance symptoms captured by a parent-report questionnaire. We conclude
that this eye tracking paradigm is sensitive to clinically meaningful variation in social avoidance behavior
and may hold promise as an outcome measure for FXS clinical trials.
Utility of the Social Gaze Eye Tracking Paradigm as an Outcome Measure in FXS Clinical Trials
Progress in the development of pharmaceutical treatments for FXS has been blocked, in part, by
the lack of appropriate outcome measures (Berry-Kravis et al., 2013; Budimirovic et al., 2017;
Jacquemont et al., 2014). The measurement of social anxiety-related behavior, in particular, has proven
challenging. A recent National Institutes of Health Working Group on outcome measures for FXS clinical
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trials concluded that few suitable anxiety measures are currently available for use in clinical trials (BerryKravis et al., 2013). The development of useful social anxiety outcome measure is a worthwhile objective
because social anxiety represents a clinically impairing, neurobiologically-relevant aspect of the FXS
phenotype. Social anxiety-related behaviors, such as social avoidance, represent common targets in FXS
clinical trials (Wright, 2016). We propose that the social gaze eye tracking paradigm used in the present
study could serve as a useful outcome measure for FXS clinical trials. We provide initial evidence of
convergent validity, as the information gleaned from the social gaze eye tracking paradigm was highly
predictive of examiner-rated social avoidance behavior sampled from a semi-naturalistic social greeting
context.
Prior clinical trials focused on social avoidance outcomes in FXS have relied predominately on
parent-report questionnaires. Overreliance on parent-report tools has been identified as a limiting factor in
the success of extant FXS clinical trials because these types of measures are subject to rater bias and
placebo effects and most capture gross behaviors that likely lack sensitivity to subtle behavioral
improvement (Budimirovic et al., 2017). The ADAMS, which was examined as a parent-reported social
avoidance measure in the present study, has been used as an outcome in several FXS clinical trials (e.g.,
Berry-Kravis et al., 2017; Ligsay et al., 2017). Our results suggest the social gaze eye tracking paradigm
may be more sensitive to subtle variation in social avoidance behavior than the ADAMS. The first
fixation duration in response to averted gaze was a robust predictor of social avoidance behavior
exhibited by the participants during initial greeting with the examiner, with a large effect size. In contrast,
parent-reported symptom severity on the ADAMS was not a significant predictor of performance in the
semi-naturalistic context, with a small-to-medium effect size. Compared to the ADAMS, the social gaze
eye tracking paradigm was better able to capture subtle behavioral information that mapped closely onto
social avoidance behavior exhibited in a semi-naturalistic setting.
Another advantageous feature of the social gaze eye tracking paradigm is that it can be used
across the full range of cognitive skills observed in the FXS population, at least in adolescent or older
individuals. The present sample consisted of low-functioning males with FXS, demonstrating
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appropriateness for use with individuals with moderate ID. Overall, 89% of males with FXS who were
initially recruited into the study were able to participate in the eye tracking assessment; higher success
rates may be achieved in future work with the implementation of behavioral training techniques or the use
of calibration targets with increased visual appeal (two participants were unable to contribute useable data
because of failure to attend to the calibration targets). In our prior work, we have also demonstrated that
the social gaze eye tracking paradigm is also sensitive to FMR1-related social phenotypes in individuals
with the FMR1 premutation, providing evidence that the task is also valid and appropriate for individuals
who do not have intellectual impairment (Klusek et al., 2017).
A final strength of the social gaze eye tracking paradigm is that it is feasible for wide-scale
administration. Relatively little staff training is required to run the eye tracker, which is advantageous
compared to traditional behavioral coding methods such as the Social Avoidance Scale, which necessitate
time-consuming training and reliability procedures. Moreover, post-collection processing of the eye
tracking data is essentially automated (the program was configured to automatically generate a results file
containing all of the relevant data). The relatively quick administration time also improves feasibility.
Average administration time in this study was about 15-20 minutes. However, our results suggest that
simple modifications could shorten the administration time to about 5-10 minutes while maintaining
validity. Specifically, the longest observed initial fixation duration was less than 1 second in length,
suggesting that the 6-second display time could be shorted to about 2 seconds without data loss. Although
cost has represented a barrier to the use of eye tracking technology in the past, advances in technology
have allowed for the development of many affordable systems in the $1-10k range that offer acceptable
accuracy and precision, such as the Gazepoint GP3 HD 105 Hz system and the Pupil-Labs Eye Camera.
Overall, our results are in line with others who have drawn attention to the promise of eye
tracking indices to improve the measurement of outcomes for FXS clinical trials (e.g., Budimirovic et al.,
2017; Farzin et al., 2009). For example, preliminary findings from a recent Novartis AFQ056 phase 2
FXS clinical trial suggest that eye tracking indices revealed treatment effects whereas traditional
caregiver-reported behavioral ratings did not (Berry-Kravis et al., 2016; Hessl et al., 2019). In that clinical
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trial, the eye tracking paradigm described by Farzin et al. (2009) was used as an outcome measure. This
paradigm consists of facial stimuli that are displayed for a 3-second interval, with the number of fixations
on the eye region used as the outcome measure of interest. Compared to the Farzin protocol, the social
gaze eye tracking paradigm employed here has some key differences. First, our eye tracking metric used a
gaze-contingent trigger to initiate the onset of the trial, which guaranteed that participants were attending
to the eyes at the onset of the trial. Additionally, the use of the first fixation duration on the eyes as the
outcome variable ensured that sustained attention to the screen was not necessary for participants to
contribute valid data. The first fixation is a relatively brief index, averaging at about one-third of a
second in duration within the FXS group. In contrast, the Farzin protocol may be more vulnerable to
missing data as participants must sustain attention to the facial stimuli for a 3-second interval in order to
validly capture the total number of fixations on the eyes. In the present study, we were successful at
obtaining valid data on >80% of trials for all participants who completed the eye tracking task, whereas
the proportion of trials in which valid data were captured sometimes dipped below 80% in the Farzin
protocol of the AFQ056 clinic trial (Hessl et al., 2019). A strength of the Farzin paradigm is that testretest reliability has been established (Farzin et al., 2011) and preliminary data supports its sensitivity to
subtle changes following mavoglurant treatment, which is significant (Hessl et al., 2019). Follow-up is
needed to determine the test-retest reliability of the social gaze eye tracking paradigm used in the current
report. Direct comparison of the social gaze eye tracking paradigm and the Farzin eye tracking paradigm
in future work would be useful to inform the relative strengths and weaknesses of each methods.
Boys with FXS did not Show Avoidance of Direct Gaze Stimuli
Because direct eye contact is thought to represent a fear-associated stimulus in FXS (e.g., Cohen
et al., 1989), we hypothesized that the males with FXS would show avoidance of the direct gaze stimuli,
marked by shorter initial fixation on eyes displaying direct gaze relative to averted gaze. Contrary to
expectations, males with FXS showed similar first fixation durations on the eyes across the direct and
averted gaze conditions. The typically developing control males also did not differentiate between direct
and averted gaze in their initial fixation times, suggesting that this was a “normal” response. Thus, we did
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not detect evidence that the males with FXS showed aversion to direct gaze, at least as indexed by
performance on the social gaze eye tracking paradigm. It is possible that the animated facial stimuli were
too far removed from real-life interaction to elicit the expected fear-related response.
We did find, however, that the males with FXS showed shorter initial fixation in the eye region in
both conditions relative to their typically developing peers, which may suggest general avoidance of the
eyes that occurs in FXS regardless of gaze direction. The lack of comparable social avoidance data in the
control males is a limitation of the present study; measurement limitations prevented the inclusion of a
social avoidance index that would be appropriate across the full range of cognitive abilities represented
across both groups. In future work, the inclusion of a developmental delay comparison group would allow
for both chronological and mental age matching and allow for further exploration into the specificity of
the relationship between the fixation data and social avoidance symptoms.
It is notable that several recent behavioral and neuroimaging studies of FXS that have also failed
to link social anxiety-related behavior with direct gaze processing. For example, in an fMRI study of gaze
processing in individuals with FXS, (Bruno, Garrett, Quintin, Mazaika, & Reiss, 2014) detected similar
neural habituation patterns following exposure to direct and averted gaze, suggesting that exposure to
direct gaze did not elicit an exaggerated neural response in individuals with FXS. In another report,
Holsen et al. (2008) failed to detect an association between social anxiety symptoms and the time that
individuals with FXS spent fixating on the eyes or other parts of the face during a facial encoding eye
tracking task. The neuroimaging data Holsen and colleagues collected during the task implicated
dysfunctional social cognitive networks rather than anxiety networks in impaired face processing in FXS.
Moreover, recent behavioral work has shown that the level of gaze avoidance exhibited by children with
FXS is independent of social task demands (Murphy et al., 2007). In light of this growing evidence base,
it may be informative to systematically detail how attentional responses to eye gaze in FXS vary
according to factors such as exposure latency and stimulus valence, which would allow us to better place
our understanding of gaze avoidance in FXS within cognitive-motivational frameworks of attentional
bias. The possibility that attentional patterns may vary as a function of anxiety disorder type and severity,
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as has been suggested in some recent reports (e.g., Salum et al., 2013; Waters, Bradley, & Mogg, 2014),
and is another prime avenue for investigation.
Shorter Initial Fixation on Averted Gaze Predicted More Severe Social Avoidance Behavior
Although we found limited evidence that initial attention to the direct gaze stimuli was associated
with social avoidance symptoms, an important finding of this study is that initial fixation on the averted
gaze stimuli was highly predictive of social avoidance behavior exhibited by the males with FXS during
initial greeting with the examiner, as indexed by the Social Avoidance Scale. The association was of a
large effect size and was present even after controlling for nonverbal cognitive level and ASD symptom
severity. The fact that performance on this relatively artificial eye tracking task mapped onto real-life
behavior so closely highlights the powerful salience of the eyes. Thus, we have demonstrated that initial
fixation duration on averted gaze tapped subtle aspects of behavior that mapped closely onto the severity
of directly observed social avoidance symptoms. A similar trend was also observed with the parent-report
social avoidance measures in which participants with FXS who showed longer initial fixation on averted
gaze tended to have lower scores on the ADAMS social avoidance subscale. While the association with
the ADAMS did not reach statistical significance, a large effect size was observed suggesting that the
model may have been underpowered. Nonetheless, the results call into question the sensitivity of parentreported metric of social avoidance with young adult-males with FXS. In particular, performance on the
eye tracking task more closely aligned with the examiner-rated social avoidance measure, and follow-up
analyses indicated that parent-reported social avoidance symptoms on the ADAMS was not predictive of
social avoidance behavior rated by the examiner.
It is curious that fixation during the averted gaze condition, but not direct gaze, was related to
social avoidance severity. Increased salience of averted gaze has also been documented in women carriers
of the FMR1 premutation (Klusek et al., 2017), suggesting that atypical social processing could be an
FMR1-mediated feature. While direct gaze has clear evolutionary significance as a signal of intent to
approach (Emery, 2000), the significance of averted gaze is context-dependent and thus may rely more
heavily on social cognitive skills to interpret. For example, neural activity in response to averted gaze
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differs when the gaze is directed towards an object versus an empty space, suggesting that the perceived
goal of averted gaze influences how it is processed (Pelphrey, Singerman, Allison, & McCarthy, 2003).
Averted gaze is often associated with joint attention skills because the ability to follow others’ gaze shifts
allows for the alignment of attentional focus between communication partners (Rothkirch, Madipakkam,
Rehn, & Sterzer, 2015). It is possible that males with FXS who fixated longer on averted gaze were more
aware of the social-cognitive implications of this signal, which translated to better performance during the
initial greeting with the examiner. This is consistent with evidence that behaviors captured by the Social
Avoidance Scale are influenced by the presence of ASD, a disorder that is characterized by central
impairments in social cognition (Roberts et al., 2018; Roberts et al., 2007). Further highlighting the
complex interlacing of social anxiety and social-cognitive features in FXS, some neuroimaging evidence
suggests that social anxiety features of FXS could be linked to the failure to engage social cognitive
networks during the initial phases of memory formation (Holsen et al., 2008). There is a need to better
understand the interface between social cognitive impairment and social anxiety and their combined
contributions to aberrant gaze processing in FXS in order to develop targeted treatments. Future
investigations specifically incorporating direct measurement of social-cognitive skills would allow for
better differentiation of the specific influences of social anxiety and social cognition on gaze processing
in FXS. Additionally, future comparison with other neurodevelopmental groups characterized by ASD/ID
could better inform aspects of atypical gaze behavior that are unique to the FXS phenotype.
Conclusion
The advancement of FXS therapeutics hinges upon the development of tools that are sensitive to
changes in core behavioral aspects of the FXS phenotype. Social avoidance is a clinically relevant,
biologically meaningful feature that is central to the FXS phenotype; yet, many existing measurement
tools have proved insufficient for capturing subtle therapeutic changes within this symptom domain.
Social avoidance and social anxiety-related behaviors are also prevalent in many other
neurodevelopmental disorders, including ASD, and the development of tools that are sensitive to social
avoidance-related phenotypes and are appropriate for use across a range of cognitive skills has
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implications for therapeutic advancement across neurodevelopmental disabilities more broadly. In this
study, we presented a novel eye tracking paradigm that may serve as a useful outcome measure in clinical
trials targeting social avoidance outcomes across individuals with a wide range of cognitive abilities.

NOVEL INDEX OF SOCIAL AVOIDANCE PHENOTYPES IN FXS

22

Acknowledgments
We would like to thank the families who participated in this study. We also appreciate the
assistance of Debra Reisinger, Emily Schworer, Sara Matherly, and Lisa Rague in conducting the
participant assessments. This research was supported by the National Institutes of Health (F32DC013934;
R01HD024356; U54HD079125, R01MH107573) and the Research Participant Registry Core of the
Carolina Institute for Developmental Disabilities (P30HD03110).

Conflicts of Interest
L.A. is currently serving as an advisor to Fulcrum Therapeutics and has received funding in the
past to implement outcome measures in clinical trials from F. Hoffmann-La Roche Ltd., Roche TCRC,
Inc., and Neuren Pharmaceuticals Ltd. The authors have no others conflicts to disclose.

NOVEL INDEX OF SOCIAL AVOIDANCE PHENOTYPES IN FXS
Table 1
Demographics
Variable
FXS
n = 24
Age in years
M (SD)
Range
Full Scale IQ
M (SD)
Range
Race n (%)
African American
Asian
Caucasian
Other
Not Specified

Group
Typical Development
n = 23

19.28 (2.67)
16.00-26.00

21.70 (1.96)
19.00-26.00

39.42 (5.82)
36.00-56.00

n/a

3 (13.04)12.5
1 (4.35)4.17
18 (78.26)75.0
0 (0)
2 (4.35) 8.33

0 (0)
0 (0)
22 (95.65)
1 (4.35)
0 (0)

23

24
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Table 2
Descriptive statistics
Group
FXS
Mean (SD)
Range

Typical Development
Mean (SD)
Range

First Fixation Duration in ms: Direct Condition
(untransformed)

372.17 (145.38)
212.50-937.75

925.30 (653.67)
255.75-2868.63

First Fixation Duration in ms: Averted Condition
(untransformed)

380.51 (166.94)
184.38- 931.25

966.40 (751.38)
191.00-3568.88

First Fixation Duration: Direct Condition
(transformed)

0.9971 (0.0008)
0.9953-0.9989

0.9984 (0.0010)
0.9961-0.9997

First Fixation Duration: Averted Condition
(transformed)

0.9970 (0.0010)
0.9946-0.9989

0.9984 (0.0011)
0.9948-0.9997

Variable

ADAMS, Social Avoidance Subscale
Social Avoidance Scale, Total Score
ADOS-2, Calibrated Severity Score
Leiter-R, Brief IQ Growth Scale Value

4.50 (2.73)
0-9.00
2.18 (0.87)
1.00-3.67
5.38 (2.53)
1.00-10.00
466.48 (8.84)
448.00-484.00

n/a
n/a
n/a
n/a

Note. ADAMS= Anxiety Depression and Mood Scale; ADOS-2= Autism Diagnostic Interview Schedule2; Leiter-R= Leiter International Performance Scale-Revised.

NOVEL INDEX OF SOCIAL AVOIDANCE PHENOTYPES IN FXS

25

Figure 1.
Example Stimuli from the Social Gaze Eye Tracking Paradigm

Note. The eye region area of interest is marked with a white rectangle. Trials begin with the eyes closed
(leftmost image) for 1200 ms. After the participants looks in the eye region for 300 ms the trial proceeds
and the eyes open to display either direct gaze (top right image) or averted gaze (bottom right image).
Figure is reproduced from Klusek et al. (2017).
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Figure 2.
Relationship between Parent-reported Social Avoidance Symptoms and First Fixation Duration in the Eye
Region

Note. Model-predicted values are presented, controlling for nonverbal cognitive ability and ASD severity.
The first fixation duration variable relates to transformed data (power transformation of λ = -1.00).
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Figure 3.
First Fixation Duration in the Eye Region as a Predictor of Social Avoidance Behavior Sampled from a
Semi-Naturalistic Context

Note. Model-adjusted values are shown, controlling for nonverbal cognitive ability and ASD severity. A
higher score on the Social Avoidance Scale reflects increased socially avoidant behavior. The first
fixation duration variable relates to transformed data (power transformation of λ = -1.00).
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